abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
No open-market purchases or sales by abrdn Life Sciences Investors insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $156.8M in total; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 86
- 13F valueReported value at the end of Q2 2026
- $156.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 182.2K
- Shares sold short
- Change
- −10.4K
- −5.4% vs. previous
- Days to cover
- 1.71
- At average daily volume
Superinvestors holding HQL, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding HQL at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by abrdn Life Sciences Investors insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)2:36 PM ET | Jul 16 | 4 days | Mahai Chris LaVictoireDirector | PPurchase | +527 | $19.92 | +$10.5K | New position527 after | |
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Pittard ChristianDirector | PPurchase | +7.92K | $16.88 | +$133.7K | New position7.92K after | |
| Sep 23, 2025 (view filing) | Sep 19-22 | 4 days | Saba Capital Management, L.P.10% Owner | SSale | −48.6K | $14.13 | −$687.1K | −1.7%2.84M after | 2 lots |
| Sep 19, 2025 (view filing) | Sep 17-18 | 2 days | Saba Capital Management, L.P.10% Owner | SSale | −64.5K | $14.04 | −$906.1K | −2.2%2.89M after | 2 lots |
| Sep 17, 2025 (view filing) | Sep 15-16 | 2 days | Saba Capital Management, L.P.10% Owner | SSale | −2.73K | $14.03 | −$38.2K | −0.1%2.95M after | 2 lots |
| Sep 15, 2025 (view filing) | Sep 11 | 4 days | Saba Capital Management, L.P.10% Owner | SSale | −15.1K | $14.28 | −$215.9K | −0.5%2.95M after | |
| Sep 4, 2025 (view filing)10:52 AM ET | Sep 2 | 2 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −14.1K | $14.04 | −$197.7K | −0.5%2.97M after | |
| Sep 2, 2025 (view filing)2:40 PM ET | Aug 29 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −23.7K | $13.89 | −$329.5K | −0.8%2.98M after | |
| Aug 27, 2025 (view filing)5:45 PM ET | Aug 26 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −400 | $13.83 | −$5.53K | 0.0%3.01M after | |
| Aug 25, 2025 (view filing)9:43 AM ET | Aug 21 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −10.7K | $14.07 | −$150.7K | −0.4%3.01M after |
Top 10 13F holders, Q2 2026
See all 86 holdersThe largest institutional positions in abrdn Life Sciences Investors at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,771,848 | $35.5M | 0.00% | +200,834+12.8% | Added |
| Penserra Capital Management LLC | 838,890 | $16.8M | 0.13% | +32,002+4.0% | Added |
| Raymond James Financial Inc | 689,134 | $13.8M | 0.00% | +27,822+4.2% | Added |
| LPL Financial LLC | 514,161 | $10.3M | 0.00% | +35,359+7.4% | Added |
| Allspring Global Investments Holdings, LLC | 455,124 | $9.11M | 0.01% | +92,589+25.5% | Added |
| Needham Investment Management LLC | 443,041 | $8.87M | 0.27% | +13,468+3.1% | Added |
| Flagship Harbor Advisors, LLC | 400,765 | $8.02M | 0.31% | +18,048+4.7% | Added |
| Ameriprise Financial Inc | 195,451 | $3.91M | 0.00% | +3,690+1.9% | Added |
| Advisors Asset Management, Inc. | 169,812 | $3.40M | 0.05% | +9,394+5.9% | Added |
| 180 Wealth Advisors, LLC | 152,829 | $3.06M | 0.31% | +3,271+2.2% | Added |
Holders of 5% or more of HQL
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of abrdn Life Sciences Investors.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Trust Portfolios LP | 13G/A | 11.34%3.55M shares | +1.25 ppfrom 10.09% | Jan 21, 20216 filings | Oct 14, 2026 | SEC |
Politician trades
All politician trades in HQL1 member of Congress reported 3 trades in abrdn Life Sciences Investors since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Nov 3, 2022 |  Thomas R. Carper Senate · DE | Sell (full) | $1K-$15K |
| Mar 3, 2020 | Thomas R. Carper Senate · DE | Buy | $1K-$15K |
| Mar 3, 2020 | Thomas R. Carper Senate · DE | Buy | $1K-$15K |
Senate · DE · Nov 3, 2022
Sell (full)$1K-$15K
Senate · DE · Mar 3, 2020
Buy$1K-$15K
Senate · DE · Mar 3, 2020
Buy$1K-$15K